Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for LVZPF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for LVZPF and 80,000+ other tickers.
See exactly how LVZPF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for LVZPF and 80,000+ other tickers.
Livzon Pharmaceutical Group Inc., founded in 1985 and based in Zhuhai, China, is dedicated to the research, development, manufacturing, and distribution of a wide array of pharmaceutical products, active pharmaceutical ingredients (APIs), and related intermediates. The company's diverse range of medications includes Ilaprazole enteric-coated tablets for treating duodenal ulcers and reflux esophagitis, and Laprazole sodium for injection to manage peptic ulcer hemorrhage. It also offers Leuprorelin Acetate Microspheres for injection and Urofollitropin for injection to address anovulation and…
No recent news available.